Data and Information

Executives weigh in on current valuations and hype around AI in the healthcare sector and what it could mean for the future.

Next year, AI will move beyond administrative support to become a workflow-integrated tool that drives predictive and proactive care and sees true adoption, according to healthcare leaders.

HIMSS Media editors discuss 2025 healthcare trends, including a shift toward mature AI use cases, scrutiny about ROI and regulation gaps as executives wrestle with choosing vendor partners and implementing AI tools.

Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.

Doug Meil, author of The Rise and Fall of Explorys and IBM Watson Health: A Personal Memoir of a Healthcare Moonshot that Misfired, discusses some lessons learned from that era, and offers perspective on where artificial intelligence may be headed next.

Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.

Atropos Health CEO, Brigham Hyde, discusses the integration of Atropos' agentic AI agent into Microsoft Teams, helping clinical teams analyze patient information and clinical documentation during team meetings to support decision making.

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.